-
1
-
-
20444457071
-
The effects of 12months of growth hormone replacement therapy on cardiac autonomic tone in adults with growth hormone deficiency
-
Tanriverdi F., Eryol N.K., Atmaca H., et al. The effects of 12months of growth hormone replacement therapy on cardiac autonomic tone in adults with growth hormone deficiency. Clin. Endocrinol. (Oxf) 2005, 62(6):706-712.
-
(2005)
Clin. Endocrinol. (Oxf)
, vol.62
, Issue.6
, pp. 706-712
-
-
Tanriverdi, F.1
Eryol, N.K.2
Atmaca, H.3
-
2
-
-
0033022245
-
High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: preliminary results
-
Erfurth E.M., Bulow B., Eskilsson J., et al. High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: preliminary results. Growth Horm. IGF Res. 1999, 9(Suppl. A):21-24.
-
(1999)
Growth Horm. IGF Res.
, vol.9
, Issue.SUPPL. A
, pp. 21-24
-
-
Erfurth, E.M.1
Bulow, B.2
Eskilsson, J.3
-
3
-
-
0034453501
-
Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors
-
Bulow B., Hagmar L., Eskilsson J., et al. Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. J. Clin. Endocrinol. Metab. 2000, 85(2):574-584.
-
(2000)
J. Clin. Endocrinol. Metab.
, vol.85
, Issue.2
, pp. 574-584
-
-
Bulow, B.1
Hagmar, L.2
Eskilsson, J.3
-
4
-
-
58649090249
-
Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly
-
Tanriverdi F., Yapislar H., Karaca Z., et al. Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly. Growth Horm. IGF Res. 2009, 19(1):24-30.
-
(2009)
Growth Horm. IGF Res.
, vol.19
, Issue.1
, pp. 24-30
-
-
Tanriverdi, F.1
Yapislar, H.2
Karaca, Z.3
-
5
-
-
0025333249
-
Premature mortality due to cardiovascular disease in hypopituitarism
-
Rosen T., Bengtsson B.A. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet Aug 4 1990, 336(8710):285-288.
-
(1990)
Lancet
, vol.336
, Issue.8710
, pp. 285-288
-
-
Rosen, T.1
Bengtsson, B.A.2
-
6
-
-
77955927055
-
Body composition, serum IGF-1 and leptin level changes in amateur boxers: retired boxers have risk factors for cardiovascular disorder
-
Tanriverdi F., Kocyigit I., Unluhizarci K., et al. Body composition, serum IGF-1 and leptin level changes in amateur boxers: retired boxers have risk factors for cardiovascular disorder. Obes. Metab. 2008, 4(2):118-123.
-
(2008)
Obes. Metab.
, vol.4
, Issue.2
, pp. 118-123
-
-
Tanriverdi, F.1
Kocyigit, I.2
Unluhizarci, K.3
-
7
-
-
0034508497
-
Fibrinolytic factors and atherothrombotic events: epidemiological evidence
-
Folsom A.R. Fibrinolytic factors and atherothrombotic events: epidemiological evidence. Ann. Med. 2000, 32(Suppl. 1):85-91.
-
(2000)
Ann. Med.
, vol.32
, Issue.SUPPL. 1
, pp. 85-91
-
-
Folsom, A.R.1
-
8
-
-
70350108621
-
Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients
-
Jax T.W., Peters A.J., Plehn G., et al. Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients. Cardiovasc. Diabetol. 2009, 8:48.
-
(2009)
Cardiovasc. Diabetol.
, vol.8
, pp. 48
-
-
Jax, T.W.1
Peters, A.J.2
Plehn, G.3
-
9
-
-
30844436819
-
Massive cardiac thrombosis in a patient with Sheehan's syndrome
-
Tanriverdi F., Gul A., Gul I., et al. Massive cardiac thrombosis in a patient with Sheehan's syndrome. Endocr. J. 2005, 52(6):709-714.
-
(2005)
Endocr. J.
, vol.52
, Issue.6
, pp. 709-714
-
-
Tanriverdi, F.1
Gul, A.2
Gul, I.3
-
10
-
-
0032454414
-
The Growth Hormone Research Society consensus guidelines for the diagnosis and treatment of adult GH deficiency
-
Hartman M.L. The Growth Hormone Research Society consensus guidelines for the diagnosis and treatment of adult GH deficiency. Growth Horm. IGF Res. 1998, 8(Suppl. A):25-29.
-
(1998)
Growth Horm. IGF Res.
, vol.8
, Issue.SUPPL. A
, pp. 25-29
-
-
Hartman, M.L.1
-
11
-
-
0028258062
-
High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults
-
Johansson J.O., Landin K., Tengborn L., et al. High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arterioscler. Thromb. 1994, 14(3):434-437.
-
(1994)
Arterioscler. Thromb.
, vol.14
, Issue.3
, pp. 434-437
-
-
Johansson, J.O.1
Landin, K.2
Tengborn, L.3
-
12
-
-
0034082939
-
Increase of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement
-
Kvasnicka J., Marek J., Kvasnicka T., et al. Increase of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement. Clin. Endocrinol. (Oxf) 2000, 52(5):543-548.
-
(2000)
Clin. Endocrinol. (Oxf)
, vol.52
, Issue.5
, pp. 543-548
-
-
Kvasnicka, J.1
Marek, J.2
Kvasnicka, T.3
-
13
-
-
34548794192
-
Markedly impaired fibrinolytic balance contributes to cardiovascular risk in adults with growth hormone deficiency
-
Devin J.K., Blevins L.S., Verity D.K., et al. Markedly impaired fibrinolytic balance contributes to cardiovascular risk in adults with growth hormone deficiency. J. Clin. Endocrinol. Metab. 2007, 92(9):3633-3639.
-
(2007)
J. Clin. Endocrinol. Metab.
, vol.92
, Issue.9
, pp. 3633-3639
-
-
Devin, J.K.1
Blevins, L.S.2
Verity, D.K.3
-
14
-
-
70449522171
-
Lack of change in insulin levels as a biological marker of PAI-1 lowering in GH-deficient adults on r-HGH replacement therapy
-
Di Minno M.N., Palmieri V., Lombardi G., Pezzullo S., Cirillo F., Di Somma C., Valle D., Di Minno G. Lack of change in insulin levels as a biological marker of PAI-1 lowering in GH-deficient adults on r-HGH replacement therapy. Thromb. Res. 2009, 124(6):711-713.
-
(2009)
Thromb. Res.
, vol.124
, Issue.6
, pp. 711-713
-
-
Di Minno, M.N.1
Palmieri, V.2
Lombardi, G.3
Pezzullo, S.4
Cirillo, F.5
Di Somma, C.6
Valle, D.7
Di Minno, G.8
-
15
-
-
0029808713
-
Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults
-
Johansson J.O., Landin K., Johannsson G., et al. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults. Thromb. Haemost. 1996, 76(3):422-428.
-
(1996)
Thromb. Haemost.
, vol.76
, Issue.3
, pp. 422-428
-
-
Johansson, J.O.1
Landin, K.2
Johannsson, G.3
-
16
-
-
0027244445
-
Haemostatic mechanisms are normal despite increased vascular mortality in hypopituitary adults
-
Beshyah S.A., Markussis V., Harbourne T., et al. Haemostatic mechanisms are normal despite increased vascular mortality in hypopituitary adults. Horm. Metab. Res. 1993, 25(8):449-450.
-
(1993)
Horm. Metab. Res.
, vol.25
, Issue.8
, pp. 449-450
-
-
Beshyah, S.A.1
Markussis, V.2
Harbourne, T.3
-
17
-
-
33646865444
-
Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency
-
Gomez J.M., Sahun M., Vila R., et al. Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency. Clin. Endocrinol. (Oxf) 2006, 64(6):632-639.
-
(2006)
Clin. Endocrinol. (Oxf)
, vol.64
, Issue.6
, pp. 632-639
-
-
Gomez, J.M.1
Sahun, M.2
Vila, R.3
-
18
-
-
33750630132
-
Changes in prothrombin and activated partial thromboplastin time during replacement therapy with human recombinant growth hormone in growth hormone deficient adults
-
Miljic D., Miljic P., Doknic M., et al. Changes in prothrombin and activated partial thromboplastin time during replacement therapy with human recombinant growth hormone in growth hormone deficient adults. Hormones (Athens) Jul-Sep 2006, 5(3):187-191.
-
(2006)
Hormones (Athens)
, vol.5
, Issue.3
, pp. 187-191
-
-
Miljic, D.1
Miljic, P.2
Doknic, M.3
-
19
-
-
19944427824
-
Platelet hyperactivation in maintained growth hormone-deficient childhood patients after therapy withdrawal as a putative earlier marker of increased cardiovascular risk
-
Reis F., Campos M.V., Bastos M., et al. Platelet hyperactivation in maintained growth hormone-deficient childhood patients after therapy withdrawal as a putative earlier marker of increased cardiovascular risk. J. Clin. Endocrinol. Metab. 2005, 90(1):98-105.
-
(2005)
J. Clin. Endocrinol. Metab.
, vol.90
, Issue.1
, pp. 98-105
-
-
Reis, F.1
Campos, M.V.2
Bastos, M.3
-
20
-
-
78649736863
-
Protein C and protein S changes in GH-deficient adults on r-HGH replacement therapy; correlations with PAI-1 and t-PA plasma levels
-
Di Minno M.N., Pezzullo S., Palmieri V., et al. Protein C and protein S changes in GH-deficient adults on r-HGH replacement therapy; correlations with PAI-1 and t-PA plasma levels. Thromb. Res. 2010, 126(6):e434-e438.
-
(2010)
Thromb. Res.
, vol.126
, Issue.6
-
-
Di Minno, M.N.1
Pezzullo, S.2
Palmieri, V.3
-
21
-
-
0034994094
-
A study of protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state
-
Dykes A.C., Walker I.D., McMahon A.D., et al. A study of protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br. J. Haematol. 2001, 113(3):636-641.
-
(2001)
Br. J. Haematol.
, vol.113
, Issue.3
, pp. 636-641
-
-
Dykes, A.C.1
Walker, I.D.2
McMahon, A.D.3
-
22
-
-
0040426308
-
High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein
-
Dahlback B., Stenflo J. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc. Natl. Acad. Sci. U.S.A. 1981, 78(4):2512-2516.
-
(1981)
Proc. Natl. Acad. Sci. U.S.A.
, vol.78
, Issue.4
, pp. 2512-2516
-
-
Dahlback, B.1
Stenflo, J.2
-
23
-
-
0842328856
-
Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex
-
(103)
-
Rezende S.M., Simmonds R.E., Lane D.A. Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. Blood 2004, 15(4):1192-1201. (103).
-
(2004)
Blood
, vol.15
, Issue.4
, pp. 1192-1201
-
-
Rezende, S.M.1
Simmonds, R.E.2
Lane, D.A.3
-
24
-
-
0022910521
-
Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor
-
Sakata Y., Loskutoff D.J., Gladson C.L., et al. Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor. Blood 1986, 68(6):1218-1223.
-
(1986)
Blood
, vol.68
, Issue.6
, pp. 1218-1223
-
-
Sakata, Y.1
Loskutoff, D.J.2
Gladson, C.L.3
-
25
-
-
55949086628
-
Protein S deficiency: a clinical perspective
-
Ten Kate M.K., van der Meer J. Protein S deficiency: a clinical perspective. Haemophilia 2008, 14(6):1222-1228.
-
(2008)
Haemophilia
, vol.14
, Issue.6
, pp. 1222-1228
-
-
Ten Kate, M.K.1
van der Meer, J.2
-
26
-
-
0021741550
-
Familial protein S deficiency is associated with recurrent thrombosis
-
Comp P.C., Nixon R.R., Cooper M.R., et al. Familial protein S deficiency is associated with recurrent thrombosis. J. Clin. Invest. 1984, 74(6):2082-2088.
-
(1984)
J. Clin. Invest.
, vol.74
, Issue.6
, pp. 2082-2088
-
-
Comp, P.C.1
Nixon, R.R.2
Cooper, M.R.3
-
27
-
-
0021740029
-
Plasma protein S deficiency in familial thrombotic disease
-
Schwarz H.P., Fischer M., Hopmeier P., et al. Plasma protein S deficiency in familial thrombotic disease. Blood 1984, 64(6):1297-1300.
-
(1984)
Blood
, vol.64
, Issue.6
, pp. 1297-1300
-
-
Schwarz, H.P.1
Fischer, M.2
Hopmeier, P.3
-
28
-
-
0024605404
-
Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study
-
(61)
-
Girolami A., Simioni P., Lazzaro A.R., et al. Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study. Thromb. Haemost. 1989, 28(1):144-147. (61).
-
(1989)
Thromb. Haemost.
, vol.28
, Issue.1
, pp. 144-147
-
-
Girolami, A.1
Simioni, P.2
Lazzaro, A.R.3
-
29
-
-
0025169536
-
Hereditary protein S deficiency in young adults with arterial occlusive disease
-
(64)
-
Allaart C.F., Aronson D.C., Ruys T., et al. Hereditary protein S deficiency in young adults with arterial occlusive disease. Thromb. Haemost. 1990, 22(2):206-210. (64).
-
(1990)
Thromb. Haemost.
, vol.22
, Issue.2
, pp. 206-210
-
-
Allaart, C.F.1
Aronson, D.C.2
Ruys, T.3
-
30
-
-
55249124089
-
Regulation of coagulation by protein S
-
Castoldi E., Hackeng T.M. Regulation of coagulation by protein S. Curr. Opin. Hematol. 2008, 15(5):529-536.
-
(2008)
Curr. Opin. Hematol.
, vol.15
, Issue.5
, pp. 529-536
-
-
Castoldi, E.1
Hackeng, T.M.2
-
31
-
-
0033780719
-
Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly
-
Sartorio A., Cattaneo M., Bucciarelli P., et al. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly. Exp. Clin. Endocrinol. Diabetes 2000, 108(7):486-492.
-
(2000)
Exp. Clin. Endocrinol. Diabetes
, vol.108
, Issue.7
, pp. 486-492
-
-
Sartorio, A.1
Cattaneo, M.2
Bucciarelli, P.3
-
32
-
-
0030319373
-
Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial
-
(125)
-
Baum H.B., Biller B.M., Finkelstein J.S., et al. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann. Intern. Med. 1996, 1(11):883-890. (125).
-
(1996)
Ann. Intern. Med.
, vol.1
, Issue.11
, pp. 883-890
-
-
Baum, H.B.1
Biller, B.M.2
Finkelstein, J.S.3
-
33
-
-
0031747438
-
Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults
-
Kann P., Piepkorn B., Schehler B., et al. Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults. Clin. Endocrinol. (Oxf) 1998, 48(5):561-568.
-
(1998)
Clin. Endocrinol. (Oxf)
, vol.48
, Issue.5
, pp. 561-568
-
-
Kann, P.1
Piepkorn, B.2
Schehler, B.3
|